|
[18F]-PI-2620 Clinical Trials
3 actively recruiting trials across 3 locations
Phoenix, Arizona1 trial
[18F]PI-2620 Phase 3 Histopathological Study
Barrow Neurological Institute
Phase 3
New Haven, Connecticut1 trial
Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
Institute for Neurodegenerative Disorders / XingImaging, LLC
Phase 2
Philadelphia, Pennsylvania1 trial
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620
Perelman Center for Advance Medicine
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.